Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-011441

SVP & General Counsel sold 3,661 shares at $10.95 ($40,088)

From the SEC's structured data for this filing

Trades in this filing

Wilson Mark Andrew · SVP & General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-16 Sale : show line 1 in the form −3,661 $10.95 $40,088 121,075 D
Open-market sales · 3,661 sh · avg $10.95 · $40,088
Loading xslF345X03/doc4.xml…